VitaDAO

VitaDAO is a decentralized collective with the primary purpose of financing and supporting early-stage longevity research. By leveraging Web3 solutions and VITA tokens, the project focuses on extending human lifespan through research, funding, and commercialization of therapeutics. The initiative aims to democratize scientific research into longevity by engaging a community-driven approach.

Members can participate in VitaDAO by acquiring VITA tokens, which can be earned or purchased. These tokens grant governance rights, allowing members to contribute either through funding or active participation in research and decision-making processes. By engaging in the community, members become co-owners of the intellectual property from funded projects, fostering involvement in advancing longevity science.

VitaDAO's uniqueness lies in its utilization of blockchain technology and decentralized governance to democratize longevity research. By issuing VITA-FAST tokens and IP-NFTs, members gain fractional ownership of intellectual property. This innovative approach empowers token holders to influence the direction of research and the commercialization of therapeutics, embodying a transparent, community-driven model for scientific advancement.

VitaDAO targets Niemann-Pick Type C disease by focusing on reactivating autophagy in Npc1 -/- cells. Their research involves advanced high-throughput screening and innovative assays to discover novel compounds with strong autophagic properties. These efforts are directed towards developing treatment methodologies, progressing into pharmacokinetics and scalability studies to explore drug translation potential.

VitaDAO operates initially on the Solana platform and leverages Ethereum blockchain technology for its token management. This dual framework facilitates the use of ERC-20 VITA-FAST tokens for fractional ownership in IP-NFTs, providing a robust and democratic governance structure and ensuring collaborative and secure participation among its community members.

VITA token holders benefit from governance rights over the intellectual property generated from funded research projects, participating in decision-making processes and directing project focus. Token holders have the opportunity to co-own the IP assets, gaining exposure to cutting-edge longevity research initiatives and contributing to the potential development of life-extending therapies.